WhaleWatch

WEEK27 Jul

NIFTY 24,384 ▲ 2.59%BANK NIFTY 57,265 ▲ 1.01%NIFTY IT 30,709 ▲ 6.75%NIFTY PHARMA 26,535 ▲ 3.86%REDINGTON 322 ▲ 24.17%BALKRISIND 2,474 ▲ 22.85%KAYNES 3,805 ▲ 19.78%FSL 302 ▲ 19.14%GALLANTT 615 ▲ 17.92%COFORGE 1,721 ▲ 15.92%CONCORDBIO 1,421 ▲ 13.80%LAURUSLABS 1,816 ▲ 13.43%SWIGGY 285 ▲ 13.30%BAJFINANCE 1,141 ▲ 12.68%NIFTY 24,384 ▲ 2.59%BANK NIFTY 57,265 ▲ 1.01%NIFTY IT 30,709 ▲ 6.75%NIFTY PHARMA 26,535 ▲ 3.86%REDINGTON 322 ▲ 24.17%BALKRISIND 2,474 ▲ 22.85%KAYNES 3,805 ▲ 19.78%FSL 302 ▲ 19.14%GALLANTT 615 ▲ 17.92%COFORGE 1,721 ▲ 15.92%CONCORDBIO 1,421 ▲ 13.80%LAURUSLABS 1,816 ▲ 13.43%SWIGGY 285 ▲ 13.30%BAJFINANCE 1,141 ▲ 12.68%

Morning brief · Sunday, 2 August 2026

Satin Creditcare's 65 percent rally may be just the beginning

Market pulse

The market found its footing and then some this past week, with the Nifty surging over two and a half percent to close at 24,384, though the real fireworks were in the technology and pharma sectors which rallied much harder. While banking stocks offered a more muted one percent gain, specific counters like Redington, Balkrishna Industries, and Kaynes Technology delivered powerful individual performances for their shareholders.

From the investor's mind

One post worth your time, explained

@ShashankUdupa1 · on X

Shashank Udupa highlighted that Torrent Pharma's recent results show the integration of JB Chem Pharma is a key factor, with management anticipating cost synergies of ₹400-450 crore over the next few years. India continues to be a primary growth engine for Torrent Pharma, experiencing a 19% year-over-year growth, which outpaced the overall pharmaceutical market. Udupa's analysis underscores the importance of the JB Chem Pharma integration for future cost savings and points to India's strong performance as a significant driver for the company's growth.

Word in the street

What the wider market is buzzing about

Satin Creditcare Network Limited

₹240Past year ▲ 65%M.cap ₹2,646 Cr

One of the most talked about stocks this past week was Satin Creditcare Network Limited, which has climbed over 65 percent in the last year. With a market capitalization around 2,646 crore rupees, the company is drawing attention for its cost to income ratio. The real story appears to be operational leverage. As the new branches added last year bring in more customers, income is expected to rise against relatively flat costs, boosting profitability. Some anticipate profits for FY27 will be a large step up from a previous 332 crore rupee figure. Others point to a conservative management team that may temper reported profits by building larger buffers for credit costs, even if performance is strong.

Yesterday's big moves